APELLIS PHARMACEUTICALS INC's ticker is and the CUSIP is 03753UAB2. A total of 12 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $250,000 | -94.0% | 165,000 | -95.2% | 0.02% | -94.1% |
| Q3 2021 | $4,192,000 | -48.5% | 3,418,000 | -22.6% | 0.25% | -52.0% |
| Q2 2021 | $8,147,000 | +286.8% | 4,418,000 | +194.5% | 0.53% | +246.7% |
| Q1 2021 | $2,106,000 | -16.3% | 1,500,000 | 0.0% | 0.15% | -15.6% |
| Q4 2020 | $2,516,000 | +132.3% | 1,500,000 | +50.0% | 0.18% | +93.5% |
| Q3 2020 | $1,083,000 | – | 1,000,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 28,825,000 | $35,498,000 | 0.69% |
| DeepCurrents Investment Group LLC | 15,079,000 | $18,525,000 | 0.55% |
| WOLVERINE ASSET MANAGEMENT LLC | 33,996,000 | $41,869,000 | 0.36% |
| Weiss Asset Management LP | 9,000,000 | $10,980,000 | 0.28% |
| SSI INVESTMENT MANAGEMENT LLC | 3,418,000 | $4,192,000 | 0.25% |
| Baker Brothers Advisors | 46,754,000 | $57,262,000 | 0.25% |
| MACKAY SHIELDS LLC | 15,855,000 | $19,641,000 | 0.18% |
| Verition Fund Management LLC | 4,310,000 | $5,350,000 | 0.05% |
| WESTWOOD HOLDINGS GROUP INC | 1,000,000 | $1,236,000 | 0.01% |
| GIRARD PARTNERS LTD. | 66,081 | $162,000 | 0.01% |